PCV88 - Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

Journal article

Open access

Peer reviewed

K M Osenenko, S A Kherraf, I A Samy, R Sambrook and A Hersi

Value in health, Vol.19(7), pp.A652-A652

11/2016

Files and links (1)

url

https://doi.org/10.1016/j.jval.2016.09.1756View

Published (Version of record) Open

1 Record Views

Title: PCV88 - Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia
Creators - without role: K M Osenenko - ICON Epidemiology, Vancouver, BC, Canada
S A Kherraf - Pfizer
I A Samy - Jeddah University
R Sambrook - ICON Epidemiology, Vancouver, BC, Canada
A Hersi - King Saud University
Publication Details: Value in health, Vol.19(7), pp.A652-A652
Publisher: Elsevier Inc
Identifiers: 9952543408331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article